Intellectual Property

Intellectual Property

Mito BioPharma has exclusive worldwide rights to develop, market, and sell the patent technology. A key patent has been recently issued in the US (March 2019).  The patent technology is exclusively licensed from Rutgers University.

Mito Biopharma has contracted Pepper Hamilton LLP as its sole patent agent.